Please assess the completion status of the following clinical trial:

Trial Title: Esmolol Infusion in Patients Undergoing Craniotomy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients with ASA physical status 1-3~* Glasgow Coma Scale:15~Exclusion Criteria:~* Patients with ASA physical status \>3,~* Body Mass Index (BMI) over 30,~* indication for rapid sequence induction,~* any contraindication for receiving b-blocker,~* chronic use of b-blocker,~* Glasgow Coma Scale (GCS) \<15,~* history of drug abuse,~* severe mental impairment,~* preoperative aphasia,~* neurologic deficit or preoperatively foreseen delayed extubation.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Esmolol (Type: ACTIVE_COMPARATOR): 500 mcg/kg of esmolol bolus 10 min before induction of anesthesia, followed by additional 200 mcg/kg/min of esmolol until 30 minutes after extubation.
- control (Type: PLACEBO_COMPARATOR): Control group did not receive esmolol or other b-blocker in the perioperative period.

Based on this trial design, predict the completion outcome and termination type (if applicable).